OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
Rixin Chen, Xin Chen, Liangping Xia, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 547

Showing 1-25 of 547 citing articles:

LNCcation: lncRNA localization and function
Mary Catherine Bridges, Amanda C. Daulagala, Antonis Kourtidis
The Journal of Cell Biology (2020) Vol. 220, Iss. 2
Open Access | Times Cited: 1112

Circular RNA: metabolism, functions and interactions with proteins
Wei‐Yi Zhou, Zerong Cai, Jia Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 874

The emerging roles of circRNAs in cancer and oncology
Lasse S. Kristensen, Theresa Jakobsen, Henrik Hager, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 188-206
Closed Access | Times Cited: 805

Circular RNA-protein interactions: functions, mechanisms, and identification
Anqing Huang, Haoxiao Zheng, Zhiye Wu, et al.
Theranostics (2020) Vol. 10, Iss. 8, pp. 3503-3517
Open Access | Times Cited: 628

Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance
Jiao Li, Dan Sun, Wenchen Pu, et al.
Trends in cancer (2020) Vol. 6, Iss. 4, pp. 319-336
Closed Access | Times Cited: 549

circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity
Botai Li, Lili Zhu, Chunlai Lu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 434

Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 424

Integrated lncRNA function upon genomic and epigenomic regulation
Allison B. Herman, Dimitrios Tsitsipatis, Myriam Gorospe
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2252-2266
Open Access | Times Cited: 373

CircRNA in cancer: Fundamental mechanism and clinical potential
Liang Chen, Ge Shan
Cancer Letters (2021) Vol. 505, pp. 49-57
Closed Access | Times Cited: 353

Review on circular RNAs and new insights into their roles in cancer
Xiaozhu Tang, Hongyan Ren, Mengjie Guo, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 910-928
Open Access | Times Cited: 269

Modulation of circRNA Metabolism by m6A Modification
Gaia Di Timoteo, Dario Dattilo, Alvaro Centrón-Broco, et al.
Cell Reports (2020) Vol. 31, Iss. 6, pp. 107641-107641
Open Access | Times Cited: 267

Specific expression and functions of circular RNAs
Sema Mısır, Nan Wu, Burton B. Yang
Cell Death and Differentiation (2022) Vol. 29, Iss. 3, pp. 481-491
Open Access | Times Cited: 245

m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao, Yuanfei Shi, Huafei Shen, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 244

The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs
Lele Zhang, Chaofeng Hou, Chen Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 236

Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224

Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
Yi Chen, Lin Yu, Yongqian Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 221

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
Xinyi Zhang, Kai Xie, Honghua Zhou, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 205

RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
Xin Wang, Linli Tian, Yushan Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 199

Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
You-Cai Yi, Xiaoyu Chen, Jing Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 192

Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 176

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 176

Colorectal liver metastasis: molecular mechanism and interventional therapy
Hui Zhou, Zhongtao Liu, Yongxiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 172

The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer
Anitha Chellamuthu, Steven G. Gray
Cells (2020) Vol. 9, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 159

Functions and clinical significance of circular RNAs in glioma
Jikui Sun, Banban Li, Chang Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 156

Page 1 - Next Page

Scroll to top